Kathryn A. Lurain, M.D., M.P.H.

Kathryn A. Lurain, M.D., M.P.H.

  • Center for Cancer Research
  • National Cancer Institute
HIV and AIDS Malignancy Branch


Dr. Lurain is an Assistant Research Physician in the HIV/AIDS Malignancy Branch. She is an expert in the treatment of a variety of HIV-associated cancers, including those caused by the Kaposi sarcoma herpesvirus (KSHV). Her primary research is based in the clinic and is focused on the development of new treatments for primary effusion lymphoma (PEL) and other KSHV-associated diseases. She is an advocate for people living with HIV and their inclusion in clinical trials. 

Areas of Expertise

Primary Effusion Lymphoma
Viral Oncology
Multicentric Castleman Disease
HIV-associated Lymphoma
Kaposi Sarcoma

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.

Clinical Trials


Selected Recent Publications

Viral, immunologic, and clinical features of primary effusion lymphoma

Lurain K, Polizzotto MN, Aleman K, Bhutani M, Wyvill KM, Gonçalves PH, Ramaswami R, Marshall VA, Miley W, Steinberg SM, Little RF, Wilson W, Filie AC, Pittaluga S, Jaffe ES, Whitby D, Yarchoan R, Uldrick TS
Blood. 133(16): 1753-1761, 2019. [ Journal Article ]

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study

Uldrick TS, Gonçalves PH, Abdul-Hay M, Claeys AJ, Emu B, Ernstoff MS, Fling SP, Fong L, Kaiser JC, Lacroix AM, Lee SY, Lundgren LM, Lurain K, Parsons CH, Peeramsetti S, Ramaswami R, Sharon E, Sznol M, Wang CJ, Yarchoan R, Cheever MA
JAMA Oncol. doi: 10.1001/jamaoncol.2019.2244: [Epub ahead of print], 2019. [ Journal Article ]

Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA

Tagawa T, Gao S, Koparde VN, Gonzalez M, Spouge JL, Serquiña AP, Lurain K, Ramaswami R, Uldrick TS, Yarchoan R, Ziegelbauer JM
Proc Natl Acad Sci. 115 (50): 12805-12810, 2018. [ Journal Article ]

A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma

Ramaswami R, Uldrick TS, Polizzotto MN, Wyvill KM, Goncalves P, Widell A, Lurain K, Steinberg SM, Figg WD, Tosato G, Whitby D, Yarchoan R
Clin Cancer Res. doi: 10.1158/1078-0432.CCR-18-3528: [Epub ahead of print], 2019. [ Journal Article ]